283 related articles for article (PubMed ID: 15867389)
1. Poly(ADP-ribose) polymerase-1 could facilitate the religation of topoisomerase I-linked DNA inhibited by camptothecin.
Park SY; Cheng YC
Cancer Res; 2005 May; 65(9):3894-902. PubMed ID: 15867389
[TBL] [Abstract][Full Text] [Related]
2. ATP modulates poly(ADP-ribose) polymerase-1-facilitated topoisomerase I-linked DNA religation in the presence of camptothecin.
Park SY; Leung CH; Cheng YC
Mol Pharmacol; 2008 Jun; 73(6):1829-37. PubMed ID: 18349103
[TBL] [Abstract][Full Text] [Related]
3. Poly(ADP-ribose) polymerase signaling of topoisomerase 1-dependent DNA damage in carcinoma cells.
D'Onofrio G; Tramontano F; Dorio AS; Muzi A; Maselli V; Fulgione D; Graziani G; Malanga M; Quesada P
Biochem Pharmacol; 2011 Jan; 81(2):194-202. PubMed ID: 20875401
[TBL] [Abstract][Full Text] [Related]
4. Delocalization of nucleolar poly(ADP-ribose) polymerase-1 to the nucleoplasm and its novel link to cellular sensitivity to DNA damage.
Rancourt A; Satoh MS
DNA Repair (Amst); 2009 Mar; 8(3):286-97. PubMed ID: 19144573
[TBL] [Abstract][Full Text] [Related]
5. Mutations of human DNA topoisomerase I at poly(ADP-ribose) binding sites: modulation of camptothecin activity by ADP-ribose polymers.
Tesauro C; Graziani G; Arnò B; Zuccaro L; Muzi A; D'Annessa I; Santori E; Tentori L; Leonetti C; Fiorani P; Desideri A
J Exp Clin Cancer Res; 2014 Sep; 33(1):71. PubMed ID: 25227992
[TBL] [Abstract][Full Text] [Related]
6. Camptothecin-sensitive relaxation of supercoiled DNA by the topoisomerase I-like activity associated with poly(ADP-ribose) polymerase-1.
Yung TM; Parent M; Ho EL; Satoh MS
J Biol Chem; 2004 Mar; 279(12):11992-9. PubMed ID: 14715657
[TBL] [Abstract][Full Text] [Related]
7. PARP-3 is a mono-ADP-ribosylase that activates PARP-1 in the absence of DNA.
Loseva O; Jemth AS; Bryant HE; Schüler H; Lehtiö L; Karlberg T; Helleday T
J Biol Chem; 2010 Mar; 285(11):8054-60. PubMed ID: 20064938
[TBL] [Abstract][Full Text] [Related]
8. Activation of topoisomerase I by poly [ADP-ribose] polymerase.
Bauer PI; Buki KG; Comstock JA; Kun E
Int J Mol Med; 2000 May; 5(5):533-40. PubMed ID: 10762658
[TBL] [Abstract][Full Text] [Related]
9. Molecular interactions between poly(ADP-ribose) polymerase (PARP I) and topoisomerase I (Topo I): identification of topology of binding.
Bauer PI; Chen HJ; Kenesi E; Kenessey I; Buki KG; Kirsten E; Hakam A; Hwang JI; Kun E
FEBS Lett; 2001 Oct; 506(3):239-42. PubMed ID: 11602253
[TBL] [Abstract][Full Text] [Related]
10. The 40 kDa carboxy-terminal domain of poly(ADP-ribose) polymerase-1 forms catalytically competent homo- and heterodimers in the absence of DNA.
Mendoza-Alvarez H; Alvarez-Gonzalez R
J Mol Biol; 2004 Feb; 336(1):105-14. PubMed ID: 14741207
[TBL] [Abstract][Full Text] [Related]
11. The expression of poly(ADP-ribose) polymerase during differentiation-linked DNA replication reveals that it is a component of the multiprotein DNA replication complex.
Simbulan-Rosenthal CM; Rosenthal DS; Hilz H; Hickey R; Malkas L; Applegren N; Wu Y; Bers G; Smulson ME
Biochemistry; 1996 Sep; 35(36):11622-33. PubMed ID: 8794742
[TBL] [Abstract][Full Text] [Related]
12. The novel poly(ADP-Ribose) polymerase inhibitor, AG14361, sensitizes cells to topoisomerase I poisons by increasing the persistence of DNA strand breaks.
Smith LM; Willmore E; Austin CA; Curtin NJ
Clin Cancer Res; 2005 Dec; 11(23):8449-57. PubMed ID: 16322308
[TBL] [Abstract][Full Text] [Related]
13. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions.
D'Amours D; Desnoyers S; D'Silva I; Poirier GG
Biochem J; 1999 Sep; 342 ( Pt 2)(Pt 2):249-68. PubMed ID: 10455009
[TBL] [Abstract][Full Text] [Related]
14. Poly(ADP-ribosyl)ation enhancement in brain cell nuclei is associated with diabetic neuropathy.
Kuchmerovska T; Shymanskyy I; Donchenko G; Kuchmerovskyy M; Pakirbaieva L; Klimenko A
J Diabetes Complications; 2004; 18(4):198-204. PubMed ID: 15207836
[TBL] [Abstract][Full Text] [Related]
15. Poly(ADP-ribosyl)ation as a DNA damage-induced post-translational modification regulating poly(ADP-ribose) polymerase-1-topoisomerase I interaction.
Yung TM; Sato S; Satoh MS
J Biol Chem; 2004 Sep; 279(38):39686-96. PubMed ID: 15247263
[TBL] [Abstract][Full Text] [Related]
16. Purification and properties of poly(ADP-ribose)polymerase from Crithidia fasciculata. Automodification and poly(ADP-ribosyl)ation of DNA topoisomerase I.
Podestá D; García-Herreros MI; Cannata JJ; Stoppani AO; Fernández Villamil SH
Mol Biochem Parasitol; 2004 Jun; 135(2):211-9. PubMed ID: 15110462
[TBL] [Abstract][Full Text] [Related]
17. Biochemical association of poly(ADP-ribose) polymerase-1 and its apoptotic peptide fragments with DNA polymerase beta.
Confer NF; Kumari SR; Alvarez-Gonzalez R
Chem Biodivers; 2004 Oct; 1(10):1476-86. PubMed ID: 17191791
[TBL] [Abstract][Full Text] [Related]
18. Poly(ADP-RIBOSE) polymerase-1 (Parp-1) antagonizes topoisomerase I-dependent recombination stimulation by P53.
Baumann C; Boehden GS; Bürkle A; Wiesmüller L
Nucleic Acids Res; 2006; 34(3):1036-49. PubMed ID: 16473854
[TBL] [Abstract][Full Text] [Related]
19. Some electron microscopic aspects of poly(ADPR) polymerase-DNA interactions and of auto-poly(ADP-ribosyl)ation reaction.
Mandel P; Jongstra-Bilen J; Ittel ME; de Murcia G; Delain E; Niedergang C; Vosberg HP
Princess Takamatsu Symp; 1983; 13():71-81. PubMed ID: 6317642
[TBL] [Abstract][Full Text] [Related]
20. Functional interactions of p53 with poly(ADP-ribose) polymerase (PARP) during apoptosis following DNA damage: covalent poly(ADP-ribosyl)ation of p53 by exogenous PARP and noncovalent binding of p53 to the M(r) 85,000 proteolytic fragment.
Kumari SR; Mendoza-Alvarez H; Alvarez-Gonzalez R
Cancer Res; 1998 Nov; 58(22):5075-8. PubMed ID: 9823314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
